Results 201 to 210 of about 415,778 (252)

Prognostic Power of Ensemble Learning in Colorectal Cancer with Peritoneal Metastasis: A Multi-Institutional Analysis. [PDF]

open access: yesBioengineering (Basel)
Bamba Y   +31 more
europepmc   +1 more source

A Rare Hepatoblastoma in a 10‐Year‐Old Boy Presenting With Tumor Rupture and Normal Alpha‐Fetoprotein Levels: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 11, November 2026.
A 10‐year‐old boy presented with a large hepatic mass (12.0 × 11.6 × 10.6 cm), classified as PRETEXT III, despite normal alpha‐fetoprotein levels (1.28 ng/mL). Tumor rupture necessitated emergency right trisectionectomy and radical colectomy. Histopathology confirmed mixed epithelial‐mesenchymal teratoid hepatoblastoma.
Christine Hyasint Paul   +13 more
wiley   +1 more source

PDK4-driven metabolic reprogramming enhances mesothelial cell invasion in colorectal cancer peritoneal metastasis. [PDF]

open access: yesActa Biochim Biophys Sin (Shanghai)
Han L   +9 more
europepmc   +1 more source

Ascites Presenting as a Peritonitis‐Like Manifestation and Liver Injury due to Trabectedin Monotherapy in a Patient With Myxoid Liposarcoma

open access: yesCancer Reports, Volume 9, Issue 11, November 2026.
ABSTRACT Background Trabectedin is a synthetic, marine‐derived antitumor agent that exerts cytotoxic effects by binding to the minor groove of DNA. While trabectedin has demonstrated efficacy in advanced soft tissue sarcomas, hepatotoxicity and other adverse events remain concerns.
Tatsuyuki Kawahara   +11 more
wiley   +1 more source

Divergent clonal evolution and tumor microenvironment remodeling shape gastric cancer peritoneal metastasis. [PDF]

open access: yesCommun Biol
Charton C   +12 more
europepmc   +1 more source

Ferroportin deficiency drives olaparib resistance in ovarian cancer via the cGAS–STING–STAT3 survival axis

open access: yesClinical and Translational Medicine, Volume 16, Issue 11, November 2026.
Abstract Background Ovarian cancer (OC) remains the most lethal gynaecological malignancy, and acquired resistance to PARP inhibitors such as olaparib represents a major clinical challenge. Although dysregulation of iron metabolism has been implicated in tumorigenesis, the specific role of the iron exporter SLC40A1 (ferroportin, FPN) in mediating ...
Jiagui Song   +10 more
wiley   +1 more source

Paraurethral Endometrioid Carcinoma Arising From Ectopic Endometriosis: A Case Report

open access: yesIJU Case Reports, Volume 9, Issue 6, November 2026.
ABSTRACT Introduction Malignant transformation of endometriosis is rare and most commonly involves the ovary; transformation from paraurethral endometriosis is exceedingly rare. Case Presentation A 73‐year‐old postmenopausal woman with prior ovarian endometrioma presented with dysuria and voiding difficulty.
Keita Ogasawara   +9 more
wiley   +1 more source

Metastatic Urachal Carcinoma With Microsatellite Stability and Low Tumor Mutational Burden Achieving a Durable Response to Pembrolizumab After Platinum Failure

open access: yesIJU Case Reports, Volume 9, Issue 6, November 2026.
ABSTRACT Introduction Urachal carcinoma is a rare and aggressive malignancy with no established systemic therapy after platinum failure. Evidence for immune checkpoint inhibitors (ICIs) remains limited, particularly in tumors without established favorable biomarkers such as microsatellite instability‐high status or high tumor mutational burden.
Fumihiro Ito   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy